Table 2.
Clinical profiles of HBV-infected patients and healthy controls
| Clinical characteristics | Patients (n = 473) | Controls (n = 238) |
|---|---|---|
| Age (years) | 51 (18–90) | 30 (18–55) |
| Male/Female | 420/53 | 159/79 |
| HBsAg | Positive | Negative |
| Anti-HCV | Negative | Negative |
| Anti-HIV | Negative | Negative |
| AFP (IU/mL) | 11.78 (0.8–400) | < 5 |
| HBV DNA (copies/mL) | 269,408 (100–11,300,000,000) | NA |
| WBC (×103/mL) | 6.4 (1.8–20.5) | NR |
| RBC (× 106/mL) | 4.1 (1.9–7.43) | NR |
| PLT (×103/mL) | 157 (6.7–641) | NR |
| AST (IU/mL) | 90 (16–7700) | NR |
| ALT (IU/mL) | 61.25 (4–4908) | NR |
| Total Bilirubin (umol/mL) | 20.7 (5.7–733) | NR |
| Direct Bilirubin (umol/mL) | 6.7 (1–450) | NR |
| Albumin (g/L) | 38.7 (16–54) | ND |
| Prothrombin (% of standard) | 85 (14–267) | ND |
| Vitamin D levels (ng/ml) | 20.42 (6.4–64.4) | 20 (11.6–85.6) |
PLT platelets, AST and ALT aspartate and alanine amino transferase, WBC white blood cells, RBC red blood cells, IU international unit, NR normal range, NA not applicable, ND not done. Values given are medians and ranges